Clodronic acid (clodronate) once weekly versus twice weekly and its effect on bone mineral density in postmenopausal osteoporosis in Italy

Trial Profile

Clodronic acid (clodronate) once weekly versus twice weekly and its effect on bone mineral density in postmenopausal osteoporosis in Italy

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Aug 2013

At a glance

  • Drugs Clodronic acid (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top